AAMDSIF is Taking a Stand for NIH Research
Research programs led by the National Institutes of Health (NIH) forge the way for life-saving new treatments for rare diseases such as aplastic anemia, MDS, and PNH. With clinical research locations throughout the U.S., researchers and clinicians discover and refine treatments for these patients, bringing hope to the bone marrow failure community.
The recent cuts to funding through the NIH have real-life impact on researchers and clinicians as well as the patients enrolled in clinical trials and receiving treatment for these diseases.
With nonpartisan partners, AAMDSIF signed this letter to Congress to reinstate full funding to programs through the National Institutes of Health.
AAMDSIF has signed on with 600 organizations and more than 3,500 people across the United States to voice our support of the NIH. For full information see the letter below.
| Attachment | Size |
|---|---|
 NIH-Community-Sign-On-Letter-with-Signatures-02.25.25-Final.pdf | 433.03 KB |
Make Your Voice Count
Your voice is important. Find out how to make your voice heard here.